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Introduction
Late endosomes (LEs), lysosomes, and lysosome-related organ-
elles are characteristically positioned by motor protein inter-
actions with cytoskeletal elements. The typical steady-state 
perinuclear positioning of LEs is dictated by the net balance of 
vectorial movements toward opposite ends of microtubules. The 
dynein–dynactin motor drives minus end (centripetal) transport, 
and at least two kinesin motors (KIF5 and KIF3) have been   
implicated in plus end (centrifugal) transport (Haimo and   
Rozdzial, 1989; Hollenbeck and Swanson, 1990; Vale et al., 
1992; Wubbolts et al., 1999; Brown et al., 2005). Other factors 
are also involved in maintaining the typical distribution of LEs, 
including small GTPases, kinases (Pelkmans et al., 2005), motor-
associated factors like huntingtin (Colin et al., 2008), and cho-
lesterol (Lebrand et al., 2002; Sugii et al., 2006).
Rab GTPases specify organelle identity (Pfeffer, 2001;   
Zerial and McBride, 2001) and control selective motor activity on 
defined compartments (Echard et al., 1998; Jordens et al., 2001, 
2005; Hoepfner et al., 2005). The small GTPase Rab7 associates 
with the LE (Zerial and McBride, 2001), and its effector Rab7-
interacting lysosomal protein (RILP) binds the p150
Glued subunit 
of the dynactin protein complex (Jordens et al., 2001; Johansson 
et al., 2007). The p150
Glued protein can bind to dynein heavy 
chain via the dynein intermediate chain (DIC), but it can also 
bind to the oppositely directed kinesin II (KIF3A) motor via 
KAP3 (Wubbolts et al., 1999; Deacon et al., 2003; Brown et al., 
2005). Kinesin I (KIF5) also drives plus end transport of LEs 
(Hollenbeck and Swanson, 1990; Nakata and Hirokawa, 1995) 
via interactions with other receptors. When p150
Glued binding to 
LEs is inhibited, the kinesin I motor remains active, resulting in 
net plus end transport (Wubbolts et al., 1999). Although Rab7 
and RILP are sufficient for the recruitment of p150
Glued-associated 
motor proteins, the actual translocation of LEs toward the   
microtubule-organizing center (MTOC) further requires III 
  L
ate endosomes (LEs) have characteristic intracellu­
lar distributions determined by their interactions with 
various motor proteins. Motor proteins associated to 
the dynactin subunit p150
Glued bind to LEs via the Rab7 ef­
fector Rab7­interacting lysosomal protein (RILP) in associ­
ation with the oxysterol­binding protein ORP1L. We found 
that cholesterol levels in LEs are sensed by ORP1L and are 
lower in peripheral vesicles. Under low cholesterol condi­
tions, ORP1L conformation induces the formation of endo­
plasmic reticulum (ER)–LE membrane contact sites. At these 
sites,  the  ER  protein  VAP  (VAMP  [vesicle­associated   
membrane protein]­associated ER protein) can interact in 
trans with the Rab7–RILP complex to remove p150
Glued 
and associated motors. LEs then move to the microtubule 
plus end. Under high cholesterol conditions, as in Niemann­
Pick type C disease, this process is prevented, and LEs ac­
cumulate at the microtubule minus end as the result of 
dynein motor activity. These data explain how the ER and 
cholesterol control the association of LEs with motor pro­
teins and their positioning in cells.
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(statin) or increased (U-18666A or siNPC1) intracellular choles-
terol levels (Fig. 1, A and C; and Fig. S1 B).
Does cholesterol affect the positioning of LEs? LysoTracker 
red–labeled LEs were followed by time-lapse fluorescence micros-
copy under the different cholesterol-manipulating conditions 
(Videos 1–3). A fraction of the LEs in cells exposed to low or high 
cholesterol conditions still moved in a bidirectional and stop and go 
manner, as in control cells. In response to high cholesterol, more 
vesicles accumulated near the nucleus and fewer in the cell periph-
ery. This is reversed under low cholesterol conditions (Fig. 1 B). 
These data suggest that cholesterol influences LE positioning.
The effect of cholesterol on motor proteins was then inves-
tigated. The Rab7 effectors RILP and ORP1L control dynein   
motor-mediated transport of LEs. To test their involvement in   
cholesterol-dependent LE positioning, these proteins were silenced 
by means of siRNA (efficient silencing was confirmed by quantita-
tive PCR [qPCR]). Cholesterol levels were then manipulated, and 
LEs were detected by staining for CD63 and ORP1L (Fig. 1 B). 
Endogenous ORP1L was bound to LEs under all cholesterol- 
manipulating settings. In addition, cholesterol manipulation did not 
affect the positioning of LEs when RILP or ORP1L was silenced.
Repositioning of LEs near the MTOC under high LE choles-
terol concentrations may require the dynein–dynactin motor.   
To test this, dynactin’s subunit p50
dynamitin was overexpressed to 
physically disrupt the motor complex (Burkhardt et al., 1997) in 
NPC1-silenced cells, and LEs were detected by CD63 labeling. 
Overexpression of p50
dynamitin abrogated clustering of LEs in 
NPC1-silenced MelJuSo cells, suggesting that functional dynein–
dynactin complexes are involved in clustering NPC1-deficient, 
cholesterol-laden LEs (Fig. 1 C).
ORP1L controls p150
Glued binding  
to Rab7–RILP
The N-terminal ankyrin repeats of ORP1L bind to Rab7 and are in-
volved in dynein motor transport of LEs (Johansson et al., 2005, 
2007). To resolve the ORP1L domains involved in the control of LE 
transport, a series of monomeric RFP (mRFP)–tagged C-terminal 
truncations of ORP1L constructs (Fig. 2 A and Fig. S2 A) were co-
expressed with GFP-RILP in MelJuSo cells. qPCR data revealed 
that the ORP1L constructs and RILP were expressed 4- to 10-fold 
over endogenous expression levels (unpublished data). RILP   
expression was required to visualize recruitment of endogenous 
p150
Glued and dynein motor binding, but the many motors present 
on a vesicle (Jordens et al., 2001) rendered localization insensitive 
to cholesterol manipulation (Fig. S1 C). Vesicles labeled by the 
mRFP-ORP1L constructs were characterized by immunostaining 
for LE labeling for CD63, LAMP-1, Rab7, and cholesterol, as de-
tected by filipin (Fig. S2, B and C). Markers for the ER, Golgi, or 
early endosomes were absent on these vesicles (Fig. S2 D).
To assess the effect of ORP1L and ORP1L mutants on   
motor recruitment and LE positioning, cells were stained for the 
dynactin motor subunit p150
Glued and DIC. Coexpression of ORP1L 
and RILP recruited p150
Glued (Fig. 2 B) and DIC to LEs (Fig. 2 C) 
that were clustered near the MTOC. Removal of the C-terminal 
ORD (ORD) prevented p150
Glued and DIC recruitment by RILP, 
resulting in the relocation of RILP-containing compartments to 
the cell periphery (Fig. 2, B and C).
spectrin and the oxysterol-binding protein (OSBP)–related   
protein 1L (ORP1L; Johansson et al., 2007). ORP1L contains a 
pleckstrin homology (PH) domain that binds phosphoinositides 
(Johansson et al., 2005), a protein-interacting FFAT (two phenyl-
alanines [FF] in an acidic tract) motif (Loewen et al., 2003; Loewen 
and Levine, 2005), and a C-terminal OSBP-related domain (ORD) 
able to bind 25-hydroxycholesterol (Im et al., 2005; Suchanek   
et al., 2007). The ER protein OSBP is related to ORP1L and 
also contains a FFAT motif that interacts with VAMP (vesicle-
associated membrane protein)-associated ER protein (VAP) A 
and VAP-B (Loewen and Levine, 2005). VAP-A and VAP-B are 
homo- or heterodimeric integral ER proteins (Nishimura et al., 
1999; Hamamoto et al., 2005) and participate in ER export of 
proteins and lipids (Wyles et al., 2002).
Cholesterol  has  been  implicated  in  LE  positioning.   
Cholesterol-laden LEs in Niemann-Pick type C patients cluster 
around the MTOC (Mukherjee and Maxfield, 2004). This pheno-
type is shared with other lysosomal storage diseases like 
Tangier, Fabry, and Gaucher (Neufeld et al., 2004; Maxfield and 
Tabas, 2005). Increasing endosomal cholesterol levels with the 
chemical compound U-18666A causes a similar phenotype 
(Roff et al., 1991; Koh and Cheung, 2006; Sobo et al., 2007). 
The LE clustering requires Rab7 and Rab9 (Lebrand et al., 
2002; Narita et al., 2005; Chen et al., 2008). Conversely, choles-
terol depletion results in LE positioning at the plus end of micro-
tubules (Sugii et al., 2006). This suggests that motor protein 
activities controlling LE positioning involve Rab GTPases and 
cholesterol, but the mechanism is unclear.
We show that cholesterol in LEs is sensed by ORP1L, 
which transmits this information to the Rab7–RILP–p150
Glued 
complex through the formation of ER–LE membrane contact 
sites (MCSs). At these sites, the ER protein VAP enters the 
Rab7–RILP complex to control p150
Glued binding and position-
ing of LEs. The characteristic clustering of LEs at the micro-
tubule minus end in Niemann-Pick type C and other lysosomal 
storage diseases is a result of this process.
Results
Chemical and genetic cholesterol 
manipulations in LEs and their positioning
Cholesterol is an essential component of cellular membranes and 
contributes to a host of different processes. To visualize the effects 
of intracellular cholesterol levels on LE positioning, MelJuSo 
cells were cultured under control or cholesterol-depleting or   
-increasing conditions. Cholesterol depletion required culturing 
cells in lipid-free medium supplemented with a statin to prevent 
the synthesis of endogenous cholesterol (Sugii et al., 2006). 
Chemical and genetic cholesterol accumulation in LEs were in-
duced by exposure of MelJuSo cells to U-18666A (Liscum and 
Faust, 1989; Kobayashi et al., 1999) or by silencing NPC1 to 
mimic Niemann-Pick type C disease (Carstea et al., 1997).
To visualize the effect of these treatments, cells were fixed 
and stained with filipin (Sobo et al., 2007) to detect cholesterol 
(Fig. 1 A and Fig. S1 B) or stained for CD63 to label LEs (Fig. 1 B 
and Fig. S1 B). Images were made at identical microscope settings 
and show that these cholesterol-manipulating treatments decreased 1211 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
Figure 1.  Chemical and genetic cholesterol manipulations and LEs. (A) Modulation of intracellular cholesterol levels. Mel  JuSo cells were cultured in normal 
medium (FCS), cholesterol-depleted medium supplemented with lovastatin (statin), or normal medium supplemented with U-18666A, as indicated. Fixed 
cells were stained with filipin to detect cholesterol. A color look up table (LUT) shows fluorescence intensities. n > 100 for each condition. (B) Effects of 
intracellular cholesterol manipulation (control [CTRL], U-18666A, or statin treatment) on LE positioning in RILP- or ORP1L-silenced Mel  JuSo cells. Cells were 
stained for the LE marker CD63 (red), endogenous ORP1L (green), and actin (blue). The position of the CD63-positive vesicles relative to the nucleus (radial 
distribution) was determined for the various conditions (>50 cells per condition), binned, and plotted (right). The distributions were statistically different 
according to the Jonckheere-Terpstra test for control siRNA (P = 1.52 × 10
5 and 7.76 × 10
6 for CD63 and ORP1L, respectively) only. No difference was 
detected for siRILP (P = 0.20 and 0.54 for CD63 and ORP1L, respectively) and for siORP1L (P = 0.29 for CD63). (C) Dynein motor activity and cluster-
ing of LEs in NPC1-silenced cells. Mel  JuSo cells were transfected with siRNA for NPC1 for 72 h and, after 48 h, transfected with an expression construct   
for p50
dynamitin to disrupt the dynein–dynactin motor. Fixed cells were stained for CD63 and p50
dynamitin to mark the overexpressing cells. n > 100. Bars:   
(A and C)10 µm; (B) 20 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1212
Figure 2.  ORP1L controls recruitment of p150
Glued to the Rab7–RILP receptor. (A) ORP1L domain structure and constructs. Five domains are predicted in 
ORP1L. Numbers indicate amino acid residue positions. Constructs were N-terminally tagged with mRFP. The ORDPHDPHD chimera had ORD exchanged 
for a tandem PH domain derived from ORP1L. (B) Effect of ORP1L deletion or chimeric constructs on RILP-mediated p150
Glued recruitment. (left) Mel  JuSo 
cells transfected with GFP-RILP and mRFP-ORP1L constructs and stained with anti-p150
Glued antibodies before CLSM. For pixel analyses of the images, see   
Fig. S2 E. n > 200 for each condition. (right) Mel  JuSo cells transfected with the indicated mRFP-ORP1L constructs and whole cell lysates analyzed by immuno-
blotting with anti-mRFP antibodies (WB: -mRFP). Molecular standards are indicated. WB, Western blot. (C) Effect of ORP1L constructs on RILP recruitment 
of the p150
Glued-associated dynein motor adapter DIC. Mel  JuSo cells were transfected with GFP-RILP and the mRFP-ORP1L constructs indicated and stained 
with anti-DIC antibodies. n > 100 for each condition. Bars, 10 µm.1213 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
of endogenous ORP1L on the phenotypes caused by the ORP1L 
mutants (unpublished data). The repositioning of LEs by the dif-
ferent ORP1L variants was confirmed in time-lapse experiments 
(Videos 4 and 5).
To test whether LE positioning requires cholesterol sens-
ing by ORP1L, MelJuSo cells were transfected with mRFP-
ORP1L before manipulating cholesterol levels. Cholesterol 
reduction by statin and lipid-free medium scattered the mRFP-
ORP1L–positive vesicles, whereas U-18666A treatment posi-
tioned LEs around the MTOC (Fig. 3 A and Fig. S3). Removal 
of the cholesterol-binding ORD or its replacement by tandem PH 
domains rendered positioning of LEs insensitive to cholesterol 
levels. ORD induced scattering of LEs under all cholesterol-
manipulated conditions, whereas ORDPHDPHD always in-
duced dense clustering (Fig. 3 B and Fig. S3). Microscopy 
analyses revealed that the expression of the ORP1L constructs 
ORP1L controls cholesterol-dependent  
LE positioning
OSBP/OSBP-related proteins are involved in nonvesicular trans-
port of sterols, and their ORDs bind and possibly extract sterols 
from membranes (Ikonen, 2008). The ORD mutant of ORP1L 
should mimic a cholesterol-free conformation of ORP1L. To test 
whether  p150
Glued  exclusion  from  Rab7–RILP  requires  ORD 
binding to membranes, ORD was exchanged for two ORP1L   
PH domains in tandem (ORDPHDPHD). Tandem PH domains 
will  increase  the  avidity  of  binding  to  phosphoinositides   
(Lemmon and Ferguson, 2000) and mimic the ORD in a membrane-
associated state. The ORDPHDPHD chimera allowed p150
Glued 
and  DIC  recruitment  by  RILP,  resulting  in  the  clustering  of 
RILP-positive compartments near the MTOC (Fig. 2, B and C). 
Silencing ORP1L with siRNA against ORD before ectopic ex-
pression of ORD or ORDPHDPHD showed no contribution 
Figure 3.  ORP1L controls cholesterol-dependent LE positioning. (A) Cholesterol-dependent ORP1L vesicle positioning. Mel  JuSo cells expressing mRFP-
ORP1L were cultured under control conditions (FCS) or conditions causing decreased (statin) or increased (U-18666A) cholesterol levels. Actin was stained 
with falloidin (green) to mark the cell boundaries before analyses by CLSM. n > 100. (B) ORP1L is dominant in vesicle repositioning as the result of choles-
terol manipulations. Mel  JuSo cells expressing mRFP-ORDPHDPHD or mRFP-ORD were treated and imaged as described in A. n > 100. Bars, 10 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1214
expressing only GFP to determine GFP lifetime under non-
FRET conditions. Again, FRET efficiency ED was decreased by 
cholesterol depletion and increased in response to enhanced 
cholesterol levels (Fig. S4 C). Cells grown under the various 
control conditions were also imaged by FLIM and showed no 
response to cholesterol manipulation, which is fully consistent 
with the results of FRET experiments measured by sensitized 
emission (Fig. S4, D and E). This shows that ORP1L senses 
cholesterol content in LEs through the C-terminal ORD.
ORP1L, cholesterol, and Niemann-Pick 
type C disease
Silencing NPC1 increases cholesterol in LEs and induces LE 
clustering. Cholesterol can distribute over the LE-limiting mem-
brane and the internal vesicles by flip-flop mechanisms and/or 
specific transporters. ORP1L senses cholesterol in the cytosolic 
leaflet of the LE-limiting membrane before translating this into 
LE repositioning. To test whether cholesterol sensing by ORP1L 
is required for LE clustering in Niemann-Pick type C, NPC1- 
silenced MelJuSo cells (Fig. S1 B) were transfected with different 
mRFP-ORP1L constructs before analysis by confocal laser- 
scanning microscopy (CLSM; Fig. 4 C). Whereas ORP1L and 
ORDPHDPHD induced clustering of LEs, ORD induced 
scattering of LEs even when NPC1 is silenced (Fig. S4 F), sug-
gesting that functional ORP1L is required to translate increased 
cholesterol levels into LE repositioning in NPC1-deficient cells.
To test whether NPC1 deficiency affects the cholesterol lev-
els in the cytosolic leaflet of LEs, intramolecular FRET of mRFP-
ORP1L-GFP was measured by sensitized emission in cells 
transfected with control or NPC1 siRNAs (Fig. 4 D). The FRET 
efficiency ED increased when NPC1 was silenced (Fig. 4 D). This 
result was confirmed in FLIM measurements (Fig. S4 G). The 
donor FRET efficiencies (ED) for mRFP-ORP1L-GFP in NPC1-
silenced cells are similar to those observed in cells treated with 
U-18666A, which mimics NPC1 deficiency (Fig. 4 B; Koh and 
Cheung, 2006; Sobo et al., 2007).
Cholesterol accumulation in LEs of NPC1-silenced cells 
may be a cause or a consequence of the LE clustering observed 
in cells of Niemann-Pick type C patients (Kobayashi et al., 
1999). To separate cholesterol accumulation from LE cluster-
ing, mRFP-ORD was expressed in NPC1-silenced cells. Fixed 
cells were stained for cholesterol with filipin (Fig. 4 E) and 
CD63 (Fig. S4 H). The CD63-positive LEs scattered by ORD 
expression  still  accumulated  cholesterol  when  NPC1  was   
silenced. This suggests that the characteristic clustering of LEs 
near the MTOC, which is typical in Niemann-Pick type C, is a 
consequence of cholesterol accumulation, as sensed by ORP1L 
(and is abrogated by ORD). ORP1L transmits this information 
to the Rab7–RILP–p150
Glued–dynein motor complex for micro-
tubule minus end–driven transport and clustering of LEs.
ORP1L conformation differs between 
peripheral and perinuclear LEs
If cholesterol levels in LEs determine its intracellular position-
ing, these levels should be different between peripheral and 
perinuclear LEs. Cholesterol levels in the cytosolic leaflet of 
LEs cannot be detected by any currently available probe other 
was increased by six- to 15-fold upon ectopic expression (un-
published data). We conclude that functional ORP1L is required 
for translating LE cholesterol content into LE positioning.
LE cholesterol affects the conformation  
of ORP1L
To determine whether LE cholesterol content affects the confor-
mation of ORP1L, an mRFP-ORP1L-GFP fusion protein was 
expressed to monitor intramolecular fluorescence resonance en-
ergy transfer (FRET). Energy transfer from a donor fluorophore 
to a suitable acceptor (Förster, 1948) is dependent on distance 
and orientation between the two fluorophores (Förster, 1948; 
Calleja et al., 2003) and was used in this study to reveal confor-
mational changes within mRFP-ORP1L-GFP (Fig. 4 A).
FRET was determined by sensitized emission using con-
focal microscopy. GFP was excited with 488-nm light, and the donor 
mRFP signal was determined. mRFP-ORP1L-GFP–expressing 
MelJuSo cells were co-cultured with MelJuSo cells expressing 
only GFP or mRFP for imaging. These latter cells served as in-
ternal controls to calculate correction factors for bleed-through 
of GFP into the mRFP channel and for direct excitation of mRFP 
by the 488-nm laser (Zwart et al., 2005). FRET and donor FRET 
efficiency (ED; i.e., FRET normalized to donor fluorophore 
input) were determined under the various cholesterol-manipulating 
conditions (Fig. 4 B). Cholesterol depletion decreased FRET   
efficiency ED, and ED was increased after LE cholesterol accu-
mulation (Fig. 4 B, right), implying that the ORP1L conforma-
tional changes were dependent on LE cholesterol content.
To exclude that these differences in ED were caused by the 
clustering of individual ORP1L molecules under the various 
conditions rather than conformational changes of each ORP1L 
molecule, the experiments were repeated with cells expressing 
both GFP-ORP1L and mRFP-ORP1L (Fig. S4 B). If changes in 
ED with mRFP-ORP1L-GFP were caused by intermolecular 
rather than intramolecular FRET, ED with GFP-ORP1L and 
mRFP-ORP1L would also change. However, ED values were 
not affected by cholesterol manipulation, implying that the 
FRET differences result from conformational changes within 
mRFP-ORP1L-GFP.
Two constructs, mRFP-ORD-GFP and mRFP-ORD-
PHDPHD-GFP, were used to test whether cholesterol-dependent 
conformational changes in ORP1L were mediated by the ORD. 
These constructs should not respond to variations in cholesterol 
levels because they lack ORD but may still respond to effects on 
the PH domain or other domains present in ORP1L. However, 
no effect of cholesterol manipulation on intramolecular donor 
FRET efficiency ED was detected, suggesting that cholesterol-
induced conformational changes in mRFP-ORP1L-GFP were 
mediated by the cholesterol-sensing ORD (Fig. S4 A).
FRET efficiencies can also be calculated from differences 
in donor fluorophore lifetime (Bastiaens and Squire, 1999). The 
aforementioned FRET experiments were repeated with FRET 
determination by fluorescence lifetime imaging microscopy 
(FLIM). The lifetime of GFP is typically 2.7 ns (Pepperkok   
et al., 1999) but decreases in the case of FRET, when energy is 
transferred to the acceptor fluorophore mRFP. Cells expressing 
mRFP-ORP1L-GFP were imaged along with control cells   1215 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
A and B, bottom). ED, as determined with mRFP-ORP1L-GFP, 
was higher on perinuclear LEs than on peripheral LEs (Fig. 5 A). 
These differences were sensed by ORD because ED was un-
affected with the mRFP-ORD-GFP construct (Fig. 5 B). This 
suggests that the positioning of LEs within one cell correlates 
with different conformations of ORP1L, as induced by different 
levels of cholesterol in the cytosolic leaflet of LEs.
than by the mRFP-ORP1L-GFP sensor (Fig. 4). We reanalyzed 
the images of cells expressing the mRFP-ORP1L-GFP FRET 
probe (Fig. 5 A) and, as a control, the mRFP-ORD-GFP FRET 
probe (Fig. 5 B). The latter construct lacks the cholesterol-sensing 
ORD. Donor FRET efficiency ED was determined in five con-
centric regions spanning the nucleus and cell surface, as indi-
cated (Fig. 5). The results were binned and quantified (Fig. 5,   
Figure  4.  LE  cholesterol  alters  the  confor-
mation of ORP1L. (A) Intramolecular FRET for 
mRFP-ORP1L-GFP. GFP and mRFP are attached 
to the same molecule, allowing FRET from do-
nor GFP to acceptor mRFP. FRET depends on 
distance  and  orientation  and  thus  indicates 
conformational changes. FRET can be detected 
by  sensitized  emission.  GFP  is  excited  by   
488-nm light, and then, after energy transfer, 
582–675-nm light emission by mRFP is detected. 
(B) Cholesterol effects on ORP1L conformation 
detected by sensitized emission. Mel  JuSo cells 
expressing  mRFP-ORP1L-GFP  were  cultured 
under  control  (FCS)  or  cholesterol-depleting 
(statin) or -enhancing (U-18666A) conditions 
before imaging by CLSM for FRET determina-
tion. Panels show the GFP signal, the mRFP 
signal, calculated FRET, and FRET related to 
donor fluorophore input: the donor FRET effi-
ciency (ED). The color LUT visualizes the differ-
ences in the ED panels. (right) quantification of 
the donor FRET efficiency detected for mRFP-
ORP1L-GFP  under  the  different  conditions  of 
cholesterol  manipulation.  The  mean  and  SD 
from two experiments (>10 cells analyzed) are 
shown (*, P = 0.05; **, P = 0.03). (C) ORP1L 
controls LE positioning in NPC1-silenced cells. 
Mel  JuSo  cells  were  transfected  with  mRFP-
ORP1L, -ORD, or -ORDPHDPHD and siRNA 
for NPC1 and analyzed by CLSM. n > 100. 
(D) Sensitized emission and ORP1L conforma-
tion in NPC1-deficient cells. mRFP-ORP1L-GFP–
expressing MelJuSo cells were transfected with 
control (siCTRL) or NPC1 (siNPC1) siRNAs be-
fore imaging by confocal FRET. (right) Donor 
FRET  efficiencies  determined  in  >10  control 
siRNA– or NPC1 siRNA–transfected cells. The 
mean ± SD is shown (**, P = 5.1 × 10
6).   
(E) NPC1, cholesterol, and LE clustering. Mel  JuSo 
cells  were  transfected  with  control  or  NPC1 
siRNA and then mRFP-ORD before staining 
with filipin for cholesterol. Pixel analyses are 
shown in Fig. S2 E. n > 50 for each condition. 
Bars, 10 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1216
point mutant permitted p150
Glued binding to RILP, resulting in 
LE clustering around the MTOC.
The FFAT motif in the ER-located ORP1L homologue 
OSBP interacts with VAP-A and VAP-B, which are involved in 
protein and lipid export from the ER (Wyles et al., 2002; Loewen 
and Levine, 2005). VAP is an integral ER protein and not an ob-
vious candidate for controlling p150
Glued release from Rab7–
RILP on LE membranes. To test whether VAP could be involved 
in this release, MelJuSo cells were transfected with mRFP-ORD 
and GFP-RILP in combination with siRNA against VAP-A and 
stained for p150
Glued (Fig. 6 B). ORD expression again removed 
p150
Glued from RILP in cells transfected with control siRNA, re-
sulting in LE positioning in the cell periphery. When VAP-A was 
silenced, ORD remained associated with p150
Glued-RILP, and 
the LEs clustered around the MTOC. Identical results were ob-
tained when VAP-B was silenced (unpublished data). VAP-A si-
lencing (with four independent siRNAs) reduced VAP-A mRNA 
ORP1L-dependent recruitment of VAP and 
removal of the p150
Glued dynactin subunit
ORP1L allows RILP-induced clustering of LEs. ORD re-
locates LEs to the cell periphery, suggesting the exclusion of 
p150
Glued from RILP (Fig. 2 B). Removal of the 20-kD region 
preceding  the  ORD  restored  RILP-induced  clustering  and 
p150
Glued binding to RILP (Fig. 2 B). This region contains a pre-
dicted coiled-coil region (aa 430–463; Johansson et al., 2007) 
followed by a FFAT motif (aa 472–482; sequence, SEDEFY-
DALSD; Fig. 2 A; Loewen et al., 2003) and should contain the 
information for removal of p150
Glued from RILP. To test whether 
the FFAT motif controlled p150
Glued binding to RILP, an inacti-
vating point mutation (D478A) in the FFAT motif (Loewen et al., 
2003) was introduced in mRFP-ORD. This mutant was co-
expressed with GFP-RILP before staining for p150
Glued (Fig. 6 A). 
Whereas  ORD  excludes  RILP-mediated  recruitment  of 
p150
Glued (resulting in LE scattering), the ORDFFAT(D478A) 
Figure 5.  ORP1L conformation and LE positioning. (A and B, top) Mel  JuSo cells expressing mRFP-ORP1L-GFP (A) or mRFP-ORD-GFP (B) were imaged 
for FRET by CLSM. The GFP image, mRFP image, calculated FRET, and donor FRET efficiency ED images are indicated. ED values are shown in false colors 
(the LUT shows the corresponding values). The position of the nucleus (N) and cell boundaries are drawn in the GFP channel. The cytosol is divided by 
five concentric rings, as indicated in the ED panel. (bottom) ED values for the constructs were collected and binned for the different rings. Values are shown 
for the different rings under the corresponding image. Mean ± SEM of ED values collected for >10 cells analyzed per construct are shown. The asterisks 
indicate a statistically significant difference in ED of that bin compared to bin 1 (the most internal ring; *, P = 0.024; **, P = 0.026; ***, P = 0.0063). 
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photoactivatable (PA)-GFP–tagged VAP-A and mRFP-ORP1L 
variants (Fig. S5 A and Videos 6–8) that also showed colocaliza-
tion of VAP-A and ORP1L on moving vesicles. Accumulation of 
the ER protein VAP on LEs by ORD expression also coincided 
with the removal of p150
Glued from RILP (Fig. S5 B). We then 
tested whether the ER–LE interactions could be observed by 
manipulating cholesterol levels in MelJuSo cells in which ORP1L 
and VAP were not ectopically expressed. TAP1-GFP labeled the 
ER (Reits et al., 2000). Decreasing cholesterol levels sufficed to 
induce the arrival of ER markers on LEs, as analyzed by CLSM 
and quantified by pixel analysis (Fig. 7 B).
The localization of VAP and ORP1L was subsequently   
visualized by EM in more detail. EM has a significantly higher 
spatial resolution than CLSM, which has a maximal resolution 
of 240 nm. MelJuSo cells were transfected with GFP-ORD, 
-ORP1L, or -ORDPHDPHD together with HA-tagged VAP-A. 
After expression of the ORP1L variants was observed (by GFP 
fluorescence), cells were processed for immuno-EM and stained 
with HA antibodies to detect VAP-A (Fig. 8 A). The frequency of 
ER contacts with LEs and the surface of the LEs covered by ER 
structures was quantified (Fig. 8 B). Note that HA-VAP was 
never detected at LE membranes, excluding fusion of the LE and 
ER under these conditions. The ER, as labeled by HA-tagged 
VAP-A, had to be within 40 nm of the LE-limiting membrane to 
be considered a contact. Most LEs (>95%) interacted, often over 
large surface areas, with the ER when ORD was expressed. 
Both the number of ER–LE interactions and the surface covered 
by the ER decreased when ORP1L was expressed. Additionally, 
contact sites were almost absent when the high cholesterol con-
formation of ORP1L (ORDPHDPHD) was expressed, suggest-
ing that the cholesterol-dependent conformational state of ORP1L 
determines ER contact site formation with LEs.
To test whether cholesterol levels determine the formation 
of these contact sites, cells expressing GFP-ORP1L were cul-
tured under control (FCS) or cholesterol-increasing (U-18666A) 
or -depleting (statin) conditions, and sections were stained for 
HA-tagged VAP-A (Fig. 8 C). Under control conditions, some 
ER–LE interactions could be observed, usually over small LE 
surfaces. Whereas cholesterol accumulation in LEs (as the result 
of U-18666A) diminished these contacts, cholesterol depletion 
markedly induced formation of ER–LE contact sites (Fig. 8 D). 
These data suggest that the conformational state of ORP1L, as 
controlled by cholesterol levels, determines whether ER contacts 
the LE. This is required for the ER protein VAP to contact (and 
manipulate) the Rab7–RILP–p150
Glued complex on LEs.
Discussion
Cholesterol is a hydrophobic molecule essential for fluidity and 
microdomain formation in biomembranes. The transfer of cho-
lesterol to other organelles requires specific cholesterol-binding 
chaperones. A series of proteins with cholesterol-binding do-
mains like the steroidogenic acute regulatory protein–related 
lipid transfer domain and ORD have been identified in various 
compartments (Holthuis and Levine, 2005). Two such proteins, 
MLN64 and ORP1L, are located at LE membranes (Ikonen, 
2008). The transfer of cholesterol over LE membranes requires 
levels by >99% and VAP-B levels by 70–80%, as determined by 
qPCR. Similarly, VAP-B silencing reduced VAP-A expression by 
99% (unpublished data). Immunoblotting with VAP-A antibodies 
confirmed efficient silencing of VAP-A expression (Fig. 6 B).
Purified proteins were used to test whether VAP directly 
controls p150
Glued binding to RILP. The p150
Glued(C25) C-terminal 
domain interacts with the purified Rab7–RILP complex and 
was used for these experiments (Johansson et al., 2007). The 
ORP1L–Rab7–RILP–p150
Glued complex was first assembled 
with  purified  proteins  before VAP-A  was  added  (Fig.  6  C). 
GTP-loaded, His-tagged Rab7 was bound to metal affinity beads   
before the addition of RILP and ORP1L. The complex was 
completed by p150
Glued(C25), and nonbound proteins were re-
moved by washing after every step during the construction of 
the complex. Subsequently, purified VAP-A was added to the 
complex followed again by washing of the beads. Its effect on 
the ORP1L–Rab7–RILP–p150
Glued(C25) complex was determined 
by Western blotting (Fig. 6 C). Soluble VAP-A removed the 
C25 fragment of p150
Glued from the preassembled Rab7–RILP–
ORP1L complex.
To test whether VAP-A prevented binding of p150
Glued to 
the Rab7–RILP complex or whether VAP-A induced the release 
of p150
Glued and to determine the role of ORP1L in this process, 
various purified Rab7–RILP complexes were assembled in vitro 
(Fig. 6 D). When VAP-A was included during the assembly of 
the complex, the p150
Glued(C25) fragment still entered the com-
plex (Fig. 6 D, lanes 1 and 2). VAP-A was probably removed by 
washing during the assembly of the Rab7–RILP complex, which 
explains why VAP-A only affected C25 binding when it was 
added to the preassembled Rab7–RILP–C25 complex. The pres-
ence or absence of ORP1L in the preassembled Rab7–RILP 
complex did not affect removal of the C25 fragment of p150
Glued 
by VAP-A (Fig. 6 D, lanes 3 and 4). These data suggest that 
ORP1L is not directly involved in VAP-A–mediated removal of 
p150
Glued from the Rab7–RILP complex but probably recruits 
VAP into this complex.
To test whether VAP-A directly interacts with the C25 
fragment of p150
Glued, GST–VAP-A or GST (as a control) was 
bound  to  GST  beads,  and  purified  p150
Glued(C25)  fragment 
was added.  VAP-A interacted with the C-terminal p150
Glued(C25) 
fragment (Fig. 6 E). These in vitro reconstitution experiments 
reveal a minimal set of proteins controlling dynein motor bind-
ing to LEs that includes Rab7, RILP, p150
Glued, and the ER 
protein VAP.
ORP1L and VAP are involved in inducing 
ER–LE membrane contacts
If the integral ER protein VAP controls motor binding to LEs   
after recruitment by ORP1L, VAP should somehow contact these 
vesicles. To visualize this, MelJuSo cells were transfected with 
the various ORD variants of mRFP-ORP1L and stained for   
endogenous VAP (Fig. 7 A). Endogenous VAP accumulated on 
ORD- and, although to a lesser extent, on ORP1L-containing 
vesicles but was excluded from vesicles labeled by ORDPHD-
PHD, indicating that VAP recruitment is dependent on the con-
formation of ORP1L (Fig. 7 A). These results were confirmed   
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Figure 6.  ORP1L requires VAP-A to remove p150
Glued from Rab7–RILP. (A) Effect of the FFAT motif in ORD on RILP-mediated p150
Glued recruitment. (left) 
Mel  JuSo cells were transfected with GFP-RILP and mRFP-ORD containing a point mutation in its FFAT motif, ORDFFAT(D478A). Fixed cells were stained 
with anti-p150
Glued antibodies. n > 200. (right) Mel  JuSo cells were transfected with the mRFP-ORD or mRFP-ORDFFAT(D478A) constructs, and whole cell 
lysates were analyzed by immunoblotting with anti-mRFP antibodies (WB: -mRFP). (B) p150
Glued exclusion by ORD and VAP-A. VAP-A was silenced by 
siRNA (siVAP-A) in cells expressing GFP-RILP and mRFP-ORD. (left) Cells stained for p150
Glued. Pixel analyses are shown in Fig. S2 E. n > 100 for each 
condition. (right) Western blot analysis of cells transfected with transfection reagent (mock), control (siCTRL), or VAP-A siRNA (siVAP-A) and probed for 
-tubulin (as loading control) and anti–VAP-A antibodies. (C) VAP-A removes p150
Glued from Rab7–RILP. GTP-locked His-Rab7(Q67L) was GTP loaded and 1219 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
coupled to Talon beads before adding purified RILP, ORP1L, and p150
Glued(C25) fragments in equimolar amounts to form a preassembled ORP1L–Rab7–
RILP–p150
Glued(C25) complex. Subsequently, the complex was incubated in the presence or absence of purified VAP-A. After washing, the bead-bound 
proteins were analyzed by SDS-PAGE and Western blotting. (D) ORP1L requirements for p150
Glued removal by VAP-A. GTP-loaded His-Rab7(Q67L) was 
coupled to Talon Co
2+ beads before adding the isolated proteins indicated in equimolar amounts to form a preassembled complex. After washing, these 
complexes were exposed to isolated VAP-A or the p150
Glued(C25) fragment, as indicated, and the effects on the preformed complex were assessed by 
SDS-PAGE and Western blot analyses with antibodies, as indicated. (E) VAP-A interacts with p150
Glued. GST or GST–VAP-A was coupled to beads before 
exposure to the p150
Glued(C25) fragment. After washing, the complexes were analyzed by SDS-PAGE and Western blotting. (A–E) Molecular masses are 
indicated. WB, Western blot. Bars, 10 µm.
 
Figure  7.  Cholesterol-dependent  ORP1L-mediated  contacts  between  LEs  and  the  ER.  (A)  ORD  recruits  endogenous  VAP-A.  Mel  JuSo  cells  expressing   
mRFP-ORD, -ORP1L, or -ORDPHDPHD were stained for VAP-A. The merge panels show an overlay of the two channels, and the boxes indicate the zoomed-in 
areas. Pixel analyses of the zoomed-in areas for fluorescence distribution of the mRFP-ORP1L variants and VAP-A are shown. n > 100. (B) Mel  JuSo cells expressing 
TAP1-GFP (red) were exposed to different cholesterol manipulating conditions, as indicated. Cells were stained with antibodies for CD63 (green). Colocalization 
of the markers was determined by computational pixel analysis and visualized in blue. (right) Quantification of the colocalizing surface of the CD63-positive 
area. The mean ± SEM for >20 cells analyzed per condition is shown (*, P = 0.068; **, P = 1.55 × 10
6; ***, P = 0.0003). Bars: (A) 10 µm; (B) 5 µm.JCB • VOLUME 185 • NUMBER 7 • 2009   1220
High cholesterol content in LEs is typical for a series of 
lysosomal storage diseases with characteristic LE clustering at 
the minus end of microtubules. It has been suggested that cho-
lesterol influences LE transport involving Rab GTPases (Holtta-
Vuori et al., 2000; Lebrand et al., 2002). Minus end transport of 
transporters like ABCA1 and possibly NPC1 (Ikonen, 2008), but 
flip-flop of cholesterol may be another possibility (Hamilton, 
2003). If so, high concentrations of cholesterol in the intralumi-
nal vesicles of LEs should be reflected by high concentrations 
of cholesterol in their cytosolic leaflet.
Figure 8.  Cholesterol-dependent MCSs between LEs 
and the ER allowing in trans VAP interactions with the 
Rab7–RILP complex. (A) Electron micrographs of multi-
vesicular bodies in Mel  JuSo cells expressing HA-VAP 
and  different  variants  of  GFP-ORP1L,  as  indicated. 
Sections were stained with anti-HA antibodies detected 
with 15-nm gold particles. The gold particles are high-
lighted by red dots, and the ER membrane (containing 
HA-VAP) is indicated by blue lines. The original images   
are shown in Fig. S5 C. (B) The percentage of multi-
vesicular bodies contacting ER structures and the contact 
area between the ER and LE membranes was deter-
mined in Mel  JuSo cells expressing the ORP1L variants 
as shown in A. Over 50 multivesicular bodies were 
considered per condition. The data on contact area 
from  two  independent  quantifications  were  binned 
as indicated, and error bars show SEM. (C) Electron 
micrographs  of  multivesicular  bodies  in  HA-VAP–   
and GFP-ORP1L–expressing MelJuSo cells exposed to 
different cholesterol-manipulating conditions, as indi-
cated. Sections were stained with anti-HA antibodies 
marked by 15-nm gold particles. The gold particles are 
highlighted by red dots, and the ER membrane (con-
taining HA-VAP) is indicated by blue lines. The original 
images are shown in Fig. S5 F. (D) The percentage of 
multivesicular bodies contacting ER structures and the 
contact area between the ER and LE membranes from 
MelJuSo cells expressing ORP1L under various condi-
tions of cholesterol manipulation (as shown in C). Over 
50 multivesicular bodies were considered per condi-
tion. The data on contact area from two independent 
quantifications were binned as indicated, and error 
bars show SEM. Bars, 200 nm.1221 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
the formation of ER–LE MCSs. This allows enduring binding 
of p150
Glued–DIC–dynein motor complexes to Rab7–RILP and 
transport to the microtubule minus end.
Why cholesterol is selected to dictate LE positioning is 
unclear. Cholesterol is present in the intraluminal vesicles as 
well as the cytosolic leaflet of LEs, allowing cytosolic exposure 
of intraluminal conditions. If cholesterol levels increase with 
maturation of the LE, the resulting ORP1L-controlled Rab7–
RILP–p150
Glued–DIC–dynein motor interactions would position 
the most matured compartments at the extreme minus end of 
microtubules with “shells” of less matured vesicles surrounding 
these at more plus end locations. Newly arriving LEs would then 
first encounter the youngest LE, resulting in spatial maturation 
before encountering lysosomes. Thus, cholesterol at the LE cyto-
solic leaflet would control the positioning of these organelles. 
We have tested this by analyzing the conformation of the choles-
terol sensor ORP1L by FRET on LEs located in the perinuclear 
area versus the periphery. Donor FRET efficiency was lower in 
the cell periphery, indicating a lower cholesterol concentration.
We have visualized how the Rab7–RILP complex controls 
intracellular positioning of LEs. This process is controlled by 
cholesterol levels sensed by ORP1L to induce ER–LE contact 
sites via interaction with the ER protein VAP. In these contact 
sites, VAP interacts in trans with the Rab7–RILP receptor, pro-
moting dissociation of p150
Glued and its associated motor pro-
teins (Fig. 9). This model explains how cholesterol depletion 
causes LE scattering and high cholesterol levels induce LE clus-
tering, as observed in Niemann-Pick type C disease. We reveal 
an unexpected contribution of ER proteins in the control of LE 
intracellular positioning by motor proteins in a process con-
trolled by cholesterol.
Materials and methods
Reagents
Rabbit anti-GFP and rabbit anti-mRFP antibodies were generated using   
purified His-mRFP or His-GFP recombinant proteins as immunogen, respec-
tively. Cross-reactivity was excluded by Western blot analyses with various 
mRFP- or GFP-labeled fusion proteins. Other antibodies used were rabbit 
polyclonal  anti-NPC1  (Novus  Biologicals),  rabbit  anti-ORP1L  (gift  from   
V. Olkkonen [National Public Health Institute, Helsinki, Finland] and   
M. Johansson [Medical Research Council Centre for Developmental Neuro-
biology, London, England, UK]), rat monoclonal antitubulin antibody   
(Abcam), rabbit anti–human VAP antiserum (recognizing VAP-A; gift from 
N. Ridgway, Dalhousie University, Halifax, Nova Scotia, Canada; further 
analyses showed that this serum recognizes VAP-A only), mouse anti–calnexin 
AF8 (David et al., 1993), mouse anti-LAMP1 (BD), mouse anti-CD63   
(Vennegoor et al., 1985), mouse monoclonal anti-EEA1 (BD), rabbit anti-
Rab7 and rabbit anti-HA epitope tag (Santa Cruz Biotechnology, Inc.), 
rabbit anti–human protein disulfide-isomerase (gift from N. Bulleid, Univer-
sity of Manchester, Manchester, England, UK), mouse monoclonal Golgi-97 
(Invitrogen), mouse monoclonal anti–HA epitope tag (12CA5; Roche), and 
mouse monoclonal anti-DIC (BD). Fluorescent secondary antibodies were 
obtained from Invitrogen.
Lovastatin (or mevinolin) was purchased from EMD and converted from 
its inactive prodrug form to its open acid form before use by first dissolving the 
prodrug in ethanol and heating to 50°C for 2 h in NaOH. Na-phosphate buf-
fer was then added, and this solution was heated to 40°C for 30 min. Finally, 
the pH was adjusted to 7.3 with concentrated HCl. Mevalonate was prepared 
by dissolving mevalonolactone (Sigma-Aldrich) in a 0.05-M NaOH solution. 
The pH was adjusted to 7.0 with 0.1 M HCl. U-18666A (EMD) was dissolved 
in ethanol to a final concentration of 10 mg/ml. The lipoprotein-deficient   
serum was prepared as described previously (Goldstein et al., 1983) and 
was a gift from M. Jauhiainen (National Public Health Institute).
LEs involves the dynein–dynactin motor complex and its recep-
tor complex, Rab7–RILP–ORP1L. Because ORP1L binds both 
Rab7–RILP (Johansson et al., 2007) and cholesterol (Suchanek 
et al., 2007), we tested whether ORP1L could transfer informa-
tion on LE cholesterol content to Rab7–RILP and then to 
p150
Glued-associated motor proteins like the dynein motor. Using 
intramolecular FRET, we showed that the C-terminal ORD of 
ORP1L senses LE cholesterol. ORD can be in a membrane-
bound state (when cholesterol levels are high) or in a cytosolic, 
membrane-free conformation (when cholesterol levels are low). 
Overexpression of ORP1L or one of its mutants did not change 
cholesterol levels in LEs (unpublished data), which suggests 
that ORP1L is merely a cholesterol sensor rather than an active 
contributor to extracting and redistributing cholesterol.
When ORD is in its cytosolic conformation or absent (as in 
the truncation mutant ORD), the FFAT motif of ORP1L pre-
vents access of p150
Glued to Rab7–RILP. This does not occur when 
ORD is in the membrane-associated state (as in the chimeric 
ORDPHDPHD). The ER protein VAP is directly involved in the 
removal of the dynein–dynactin subunit p150
Glued from the Rab7–
RILP complex because silencing VAP restores p150
Glued binding 
to ORD–Rab7–RILP-containing vesicles. This was confirmed 
when purified VAP-A removed p150
Glued from the RILP–Rab7–
ORP1L complex (which also indicated that the minimal set of 
proteins involved in this process had been identified).
The ER protein VAP would not be an obvious candidate for 
regulating LE positioning. Light microscopy suggested that VAP 
localized to LEs when ORD was expressed (indicating ER–LE 
fusion). However, visualization of this process at a higher resolu-
tion by EM revealed that the ER (containing VAP) aligned to 
rather than fused with LEs, creating LE–ER contact sites. The 
formation of these contact sites is dependent on the conformation 
of ORP1L. ORD or low cholesterol levels in the LEs increased 
the number and area of contact sites, whereas ORDPHDPHD 
or high cholesterol decreased these interactions. ER–LE contact 
sites were proposed as sites where lipids like cholesterol could   
be transferred from LEs to the ER for further distribution   
(Underwood et al., 1998). However, the ER–LE contact sites are 
predominantly observed under conditions of low cholesterol and, 
to a lesser extent, under control conditions. It is possible that they 
are transiently formed when ORP1L changes conformation to 
expose the FFAT domain and released when ORP1L adopts the 
membrane-associated cholesterol-high state. Under low choles-
terol conditions when the ER–LE MCSs form, the ER protein 
VAP can interact in trans with the Rab7–RILP receptor on LEs to 
release p150
Glued. This then results in microtubule plus end trans-
port and scattering of LEs. The ER network is directly linked to 
the microtubule network that is also used by p150
Glued-associated 
motors on LEs (Vedrenne and Hauri, 2006). The ER–LE contact 
sites are relatively stable between a dynamic ER and with mov-
ing vesicles, as can be appreciated in Videos 5–7. Whether other 
proteins contribute to stabilizing interactions between these   
organelles is unclear.
When NPC1 is depleted or mutated, as in Niemann-Pick 
type C disease (Carstea et al., 1997), or when chemical drugs 
raise cholesterol levels of LEs (Roff et al., 1991; Sobo et al., 
2007), the ORD of ORP1L is membrane associated, preventing JCB • VOLUME 185 • NUMBER 7 • 2009   1222
GAGTC-3 and 5-AAGCAAGTAAAACCTCTACAAATG-3 as primers, fol-
lowed by swapping of the wild-type FFAT motif in mRFP-ORD for the 
mutated FFAT using the EcoRI and BamHI restriction sites. The ORP1L FRET 
construct (mRFP-ORP1L-GFP) was generated in two steps. First, mRFP-ORP1L 
was digested with NheI–SacI (internal site in ORP1L), which was subse-
quently cloned into pEGFP-N1 (Clontech Laboratories, Inc.) to obtain an 
N-terminal region of ORP1L, which was N-terminally tagged to mRFP and 
C-terminally  tagged  to  GFP.  In  the  second  step,  the  C-terminal  part  of 
ORP1L was produced by PCR with a forward primer (5-GGAGTGTGA-
CATGGCTAA-3) and a reverse primer (5-CGGGATTCCATAAATGTCAG-
GCAAATTGAAG-3), mutating the ORP1L stop codon. The PCR product 
was digested using SacI and BamHI and cloned into the aforementioned 
intermediate construct.
To obtain mRFP-ORDPHDPHD-GFP, mRFP-ORDPHD was subcloned 
into pEGFP-N3 (Clontech Laboratories, Inc.) using the restriction sites NheI 
and KpnI in mRFP-ORDPHDPHD (described above). The second PH do-
main in the tandem was generated by PCR using the primers 5-CGGGG-
TACCCGATATGAGGGCCCTCTCTGGAAGA-3 and 5-CGGGGTACCG-
CTGTAAGCAGAATGTTCTTCTATTGC-3 and cloned into the KpnI restric-
tion site. To obtain mRFP-ORD-GFP, mRFP-ORD was cloned into pEGFP-N2 
(Clontech Laboratories, Inc.) using the restriction sites NheI and EcoRI in 
mRFP-ORDPHDPHD (described above).
For the generation of mRFP-ORP1L, ORP1L cDNA was cloned into 
mRFP-C1 using the BglII and BamHI restriction sites. Ectopic expression of 
RILP or ORP1L resulted in an approximately fourfold or sevenfold increase 
in mRNA levels (by qPCR), respectively. Expression (analyzed by qPCR) for 
RILP, ORP1L, and VAP related to actin (set at 100%) was 1.59% (SD, 
0.01%), 2.16% (SD, 0.61%), and 1.78% (SD, 1.11%), respectively.
siRNAs for human NPC1 and ORP1L were obtained from Thermo 
Fisher Scientific (ON-TARGETplus SMARTpool for GenBank/EMBL/DDBJ 
accession nos. NM_000271 and NM_018030, respectively) and trans-
fected using DharmaFECT 1 transfection reagent (Thermo Fisher Scientific). 
cDNA constructs and vectors
Rab7, RILP, VAP-A, VAP-B, TAP1-GFP, p150
Glued(C25), and ORP1L cDNA 
constructs  have  been  described  previously  (Reits  et  al.,  2000;  Jordens   
et al., 2001; Wyles et al., 2002; Marsman et al., 2004; Johansson et al., 
2007). GST–VAP-A was a gift from M. Hardy and K. Ettayebi (Montana 
State University, Bozeman, MT), and HA–VAP-A and –VAP-B were gifts 
from C. Hoogenraad (Erasmus Medical Center, Rotterdam, Netherlands; 
Teuling et al., 2007). VAP-A was cut with BamHI–XhoI and cloned into both 
a pAGFP-C1 vector and a pYFP-C1 vector (in the BglII–SalI site). GFP-
ANKPHD and mRFP-ANKPHD were generated by subcloning the ANKPHD 
fragment from pCDNA4-ANKPHD (Johansson et al., 2007) into a pEGFP-C1 
vector (BD) or into a custom made pmRFP-C1 vector (Johansson et al., 
2007), respectively, using the BamHI and XbaI sites.
ORD was generated by PCR using the primers 5-ACTCGGATC-
CATGAACACAGAAGCGGAGCAACA-3  and  5-AAAGGATCCCTATC-
TGTGTTTTCTACTGCCCAAATGC-3 and was inserted into the BamHI site 
of pcDNA4HisMax (Invitrogen) and the BglII site of pmRFP-C1 vectors   
(Johansson et al., 2007). To generate mRFP-ORDPHDPHD, mRFP-ORD 
was digested with XbaI and EcoRI. The remainder of ORD was amplified 
by PCR using the primers 5-CTCAAAATGATTAAGGAGTGTGACATGG-
CTA-3  and  5-CCGGAATTCCATTCTGTGTTTTCTACTGCCCAAATGCTC-3. 
The amplified fragment was inserted into the XbaI and EcoRI sites of the 
previously digested mRFP-ORD vector. The first PH domain was generated 
by PCR using the primers 5-CCGGAATTCCGATATGAGGGCCCTCTCTG-
GAAGA-3 and 5-CGGGGTACCGCTGTAAGCAGAATGTTCTTCTATTGC-
3 and ligated into the EcoRI and KpnI sites. Subsequently, the second PH 
domain was also generated by PCR using the primers 5-CGGGGTACCC-
GATATGAGGGCCCTCTCTGGAAGA-3 and 5-CGGGATCCATTCTAGC-
TGTAAGCAGAATGTTCTTCTATTGC-3 and inserted using the KpnI and 
BamHI sites.
mRFP-ORDFFAT(D478A) was generated by PCR using mRFP-ORD 
as  a  template  and  5-CCCAGAATTCTATGCGGCGCTGTCAGATTCC-
Figure 9.  Model showing control of Rab7–RILP–p150
Glued motor protein complexes by the ER protein VAP, cholesterol, and the sensor ORP1L. Rab7 recruits 
the homodimeric effector protein RILP to LEs. RILP binds the p150
Glued subunit of the dynein–dynactin motor. ORP1L also binds to the Rab7–RILP complex. 
ORP1L has a C-terminal cholesterol-sensing ORD that exists in different conformational states determined by cholesterol in LEs. At low cholesterol levels, 
ORD adopts a conformation in which the adjacent FFAT motif is exposed and which can be detected by the ER protein VAP in ER–LE MCSs. VAP binds 
in trans to the Rab7–RILP–p150
Glued complex and removes p150
Glued, thus preventing minus end–directed transport. High cholesterol conditions initiate 
a different ORP1L conformation, preventing formation of ER–LE MCSs, and VAP fails to interact with the Rab7–RILP–p150
Glued complex. Thus, cholesterol 
levels in LEs determine the conformation of ORP1L and thereby VAP recruitment in ER–LE contact sites. The ER protein VAP then controls p150
Glued binding 
to Rab7–RILP, resulting in the scattering of cholesterol-poor LEs and clustering of cholesterol-laden LEs, as in Niemann-Pick type C disease.1223 CHOLESTEROL, LATE ENDOSOMES, AND THE ER • Rocha et al.
(modulation depth 70%) were fitted with a sinus function, and lifetimes 
were derived from the phase shift between excitation and emission. For in-
ternal controls, cells were co-cultured with MelJuSo cells expressing GFP 
only. Lifetimes were referenced to a 1-µM solution of rhodamine-G6 in sa-
line that was set at a 4.11-ns lifetime. The donor FRET efficiency ED was 
calculated as ED = 1  (measured lifetime/GFP lifetime in control cells) 
(Zwart et al., 2005).
Sensitized emission FRET by confocal microscopy
FRET between GFP and mRFP molecules was determined by calculating the 
sensitized emission (the mRFP emission after GFP excitation) from separately 
acquired donor and acceptor images (using an AOBS system equipped 
with a 37°C culture device at 5% CO2 and an HCX Plan-Apochromat 63× 
NA 1.32 oil-corrected objective lens). Three images were collected: GFP 
excited at 488 nm and detected between 500 and 549 nm, indirect mRFP 
excited at 488 nm and detected between 581 and 675 nm, and direct 
mRFP excited at 561 nm. Because of GFP-mRFP spectral overlap, indirect 
mRFP emission was corrected for bleed through of GFP in the 581–675-nm 
filter and for direct excitation of mRFP by 488-nm light. The correction fac-
tors were determined experimentally for each image by co-culturing cells 
expressing mRFP-ORP1L-GFP (or any of the ORP1L variants) with cells ex-
pressing only GFP (to detect the bleed through in the mRFP channel) or 
mRFP (to detect direct excitation with 488-nm light). FRET and donor FRET 
efficiency ED were calculated from these data as previously described in 
detail (van Rheenen et al., 2004; Zwart et al., 2005). For quantification of 
the intramolecular FRET gradient of mRFP-ORP1L-GFP and mRFP-ORD-
GFP, ED was measured in five equally sized concentric rings covering the 
area between the nucleus and the cell surface at the most distant point. The 
ED in each circle was collected, binned, and expressed per cell analyzed. 
The mean ED and SEM of the different cells analyzed are calculated for the 
different rings.
Immuno-EM
Cells were fixed in 2% paraformaldehyde in 0.1 M PHEM buffer (60 mM 
Pipes, 25 mM Hepes, 2 mM MgCl2, and 10 mM EGTA, pH 6.9) and 
then  processed  for  ultrathin  cryosectioning  as  previously  described 
(Calafat et al., 1997). 50-nm-thick cryosections were cut at 120°C   
using diamond knives in a cryoultramicrotome (Leica) and transferred 
with a mixture of sucrose and methylcellulose onto formvar-coated cop-
per grids. The grids were placed on 35-mm Petri dishes containing 2% 
gelatin at 37°C. The grids were incubated with the various antibodies at 
room temperature and then incubated with 10-nm protein A–conjugated 
colloidal gold (EM Laboratory, Utrecht University) as previously described 
(Calafat et al., 1997). After immunolabeling, the sections were embedded 
in a mixture of methylcellulose and 0.4% uranyl acetate and examined 
with an electron microscope (CM10; Philips). The 40-nm spacing between 
the ER and LE membranes was derived from both digital and printed 
electron micrographs.
Filipin stainings
Formaldehyde-fixed cells were stained for 2 h at room temperature with 
0.05 mg/ml filipin (Sigma-Aldrich) freshly dissolved in PBS supplemented 
with  0.5%  BSA,  and  the  staining  was  imaged  with  a  microscope   
(AxioObserver Z1; Carl Zeiss, Inc.) equipped with a charge-coupled device 
camera (ORCA-ER; Hamamatsu Photonics) and a 63× NA 1.25 Plan-
Neofluar oil-corrected objective lens. Filipin signal was recorded using a 
390–415-nm band-pass (BP) excitation filter and with a 450–470-nm BP 
emission filter. FITC signal was recorded with a 480–510-nm BP excita-
tion filter and with a 515–550-nm BP emission filter. mRFP signal was re-
corded with a 555–590-nm BP excitation filter and with a 605–655-nm 
BP emission filter (Carl Zeiss, Inc.). For data acquisition, the manufacturers’ 
software was used.
Protein purification
His-Rab7, His-RILP, and GST-ORP1L were produced as previously described 
(Johansson et al., 2007). Cells were lysed in 0.5% Triton X-100, 20 mM 
Hepes, pH 7.5, 200 mM NaCl, 8 mM -mercaptoethanol, and complete 
EDTA-free protease inhibitors cocktail (Roche). The lysate was cleared by 
centrifugation, and the supernatant was incubated with pre-equilibrated 
Talon Co
2+ resin (Clontech Laboratories, Inc.) for 30 min. The resin was then 
washed extensively with 20 mM Hepes, pH 7.5, 200 mM NaCl, and 8 mM 
-mercaptoethanol. Proteins were stored in 8.7% glycerol at 80°C until 
use in protein reconstitution experiments. GST–VAP-A construct in pGEX 
was a gift from N. Ridgway (Wyles et al., 2002). GST was removed by 
cleavage with thrombin by incubation at 30°C for 2 h before inactivation 
qPCR showed that RILP and ORP1L were expressed at <1% after siRNA   
silencing  and  VAP-A  at  0.02%.  All  constructs  were  sequence  verified.   
Expressed proteins had the expected molecular weight, as confirmed by 
SDS-PAGE and Western blot analyses.
Cell culture and drug treatment
Monolayers of MelJuSo cells were maintained in Iscove’s modified Dul-
becco’s medium (IMDM; Invitrogen) supplemented with 8% FCS in 5% CO2 
at 37°C. For cholesterol-depleting conditions, MelJuSo cells were washed with 
PBS and then cultured in IMDM supplemented with 5% lipoprotein-deficient 
serum, 50 µM lovastatin to inhibit HMG-CoA (3-hydroxy-3-methyl-glutaryl-
CoA) reductase, and 230 µM mevalonate to supply essential nonsterol iso-
prenoids for cell growth and survival (Liscum et al., 1989; Sugii et al., 
2006) for 4 h before analyses. For cholesterol enhancement, cells were 
washed with PBS and cultured in IMDM supplemented with 8% FCS and   
3 µg/ml U-18666A for 15 h before analyses.
Microscopy
Transfected cells were fixed at 48 h (DNA or RNAi) or 72 h (RNAi and 
DNA) after transfection with 4% formaldehyde in PBS for 30 min and 
permeabilized for 5 min with 0.05% Triton X-100 in PBS at room temper-
ature. Nonspecific binding of antibodies was blocked by 0.5% BSA/PBS 
for 40 min, after which cells were incubated with primary antibody in 
0.5% BSA/PBS for 1 h at room temperature. Bound primary antibodies 
were visualized with Alexa Fluor secondary antibody conjugates (Invitro-
gen). Cells were mounted in Vectashield mounting medium (Vector Labo-
ratories).  The  specimens  were  analyzed  with  confocal  laser-scanning 
microscopes (TCS-SP1, TCS-SP2, or AOBS; Leica) equipped with HCX 
Plan-Apochromat 63× NA 1.32 and HCX Plan-Apochromat lbd.bl 63× 
NA 1.4 oil-corrected objective lenses (Leica). The acquisition software 
used was LCS (Leica).
Colocalization analysis for TAP1 and CD63 was performed using 
Matlab (MathWorks), in which images were stretched to 255 Gy, and co-
localization was performed on the pixels with intensities between100 and 
255 Gy. The number of colocalizing pixels was related to total CD63 pix-
els for quantification. The colocalizing pixels were projected on the CD63/
TAP1 overlay image for representation.
Photoactivation experiments were performed in MelJuSo cells trans-
fected with PA-GFP tagged to VAP-A and cotransfected with mRFP-tagged 
ORP1L, ORP1LORD, or ORP1LORDPDHPDH. Cells were mounted in 
phenol red–free DME (Invitrogen), limiting autofluorescence of the medium. 
All measurements were performed on an AOBS system equipped with a 
37°C culture chamber and an HCX Plan-Apochromat lbd.bl 63× NA 1.4 
lens. Cells were imaged using a 488-nm and 561-nm laser to visualize the 
activated PA-GFP– and mRFP-tagged proteins, respectively. Point activation 
with full power from the 405-nm laser was performed for 3 s at the nuclear 
region, where the ER was activated at the sites below or under the nucleus. 
This location was devoid of LE structures. To confirm this, a z stack was 
made before activation.
Quantification of vesicle distribution
A mask was drawn for every cell to be quantified. Within each cell, the 
center of gravity of the stain to be quantified (e.g., CD63) was determined 
for each cell with the program CellProfiler (Broad Institute). The cell was di-
vided into six fractions from the defined center to the edge of the cell. The 
mean fractional intensity at a given radius (fraction of total intensity normal-
ized by fraction of pixels at a given radius) was determined and plotted for 
each fraction. For the modules and pipelines used, see http://cellprofiler 
.labstore.nl.
FLIM
FLIM experiments were performed with MelJuSo cells stably expressing 
mRFP-ORP1L-GFP cultured on Delta T dishes (Bioptechs). Before measure-
ments, cells were mounted in bicarbonate-buffered saline medium (140 mM 
NaCl, 5 mM KCl, 2 mM MgCl2, 1 mM CaCl2, 23 mM NaHCO3, 10 mM 
d-glucose, and 10 mM Hepes, pH 7.3) and analyzed at 37°C in a 5% 
CO2 culture hood surrounding the objective stage of the microscope.   
Images were taken on an inverted microscope (DM-IRE2; Leica) with an HCX 
Plan-Apochromat 63× NA 1.35 glycerol-corrected objective lens equipped 
with a frequency domain lifetime attachment (Lambert Instruments) con-
trolled by the manufacturer’s FLIM software (Lambert Instruments). GFP was 
excited with 4 mW of 488-nm light from a light-emitting diode modulated 
at 40 MHz, and emission was collected at 490–550 nm using an intensi-
fied charge-coupled device camera (CoolSNAP HQ; Roper Scientific). To 
calculate the GFP lifetime, the intensities from 12 phase-shifted images JCB • VOLUME 185 • NUMBER 7 • 2009   1224
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and precipitation by 0.1 mM PMSF. The GST moiety was removed using a 
glutathione-Sepharose column (GE Healthcare), and the purity of GST-free 
VAP-A was confirmed by SDS-PAGE and Coomassie staining.
In vitro VAP-A induced p150
Glued removal from the Rab7–RILP  
protein complex
The reconstitution assay was performed in a detergent/salt buffer (20 mM 
Hepes, pH 7.5, 200 mM NaCl, 4 mM -mercaptoethanol, 5 mM MgCl2, 
0.05% [vol/vol] Triton X-100, and 50 µM GTP). 15 µg His-Rab7(Q67L) 
was coupled to 3 µl of Talon Co
2+ beads and preloaded with GTP. Beads 
were washed to remove unbound His-Rab7(Q67L), and recombinant puri-
fied proteins were added in equimolar concentrations. 3 µg His-RILP, 8.7 µg 
GST-ORP1L, 2.2 µg VAP-A, and 4.5 µg maltose-binding protein (MBP)–
p150
Glued(C25) were added to the beads as indicated and incubated in 
a total volume of 0.4 ml for 2 h at 4°C. Beads were washed extensively, 
and 4.5 µg MBP-p150
Glued(C25) or 2.2 µg VAP-A was added to the beads 
as indicated. Proteins were subsequently incubated in a total volume of 
0.4 ml of detergent/salt buffer for 30 min at 22°C. Beads were washed 
extensively,  and  proteins  bound  to  His-Rab7(Q67L)  were  analyzed  by 
SDS-PAGE and Western blotting. Proteins were detected with the following 
antibodies: -His (GE Healthcare), -MBP (New England Biolabs, Inc.), 
and -GST (gift from W. Moolenaar, The Netherlands Cancer Institute,   
Amsterdam, Netherlands). Direct binding of p150
Glued to VAP-A was   
assayed as follows. 30 µg GST–VAP-A or 15 µg GST was coupled to 15 µl 
of glutathione–Sepharose 4B beads (GE Healthcare). Beads were washed 
to remove unbound proteins, and 4.5 µg MBP-p150
Glued(C25) was added 
to the beads in a total volume of 0.4 ml for 30 min at 22°C. Beads were 
washed extensively, and proteins bound to the glutathione–Sepharose 4B 
beads were analyzed by SDS-PAGE and Western blotting.
Online supplemental material
Fig. S1 shows cholesterol, NPC1, the ORD, and vesicle distribution. Fig. S2 
shows colocalization experiments of RILP and ORP1L variants with com-
partment markers and dynein motor subunits. Fig. S3 shows the chemi-
cal manipulation of cholesterol levels and location of ORP1L variants on 
LEs. Fig. S4 shows control-sensitized emission FRET and FLIM experiments, 
the effect of NPC1 silencing on ORP1L conformation, and vesicle distri-
bution of ORP1L mutants. Fig. S5 shows ORP1L-mediated recruitment of 
VAP-A from the ER and the release of p150
Glued from RILP. Videos 1–3 
show time-lapse experiments of LysoTracker red–labeled MelJuSo cells when 
cholesterol levels were manipulated. Videos 4 and 5 show time-lapse ex-
periments of MelJuSo cells in which expression of mRFP-ORD and mRFP-
ORDPHDPHD is induced and the distribution of LEs is followed. Videos 
6–8 show time-lapse experiments in MelJuSo cells expressing mRFP-ORP1L, 
mRFP-ORD,  and  mRFP-ORDPHDPHD  combined  with  photoactivation 
of PA-GFP–tagged VAP-A. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200811005/DC1.
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